表紙:動物用医薬品の市場規模・市場シェア・動向分析 (2022-2030年):製品 (生物製剤・医薬品)・動物タイプ (生産動物・コンパニオンアニマル)・送達区分 (経口・非経口)・エンドユーザー別
市場調査レポート
商品コード
1068269

動物用医薬品の市場規模・市場シェア・動向分析 (2022-2030年):製品 (生物製剤・医薬品)・動物タイプ (生産動物・コンパニオンアニマル)・送達区分 (経口・非経口)・エンドユーザー別

Veterinary Medicine Market Size, Share & Trends Analysis Report By Product (Biologics, Pharmaceuticals), By Animal Type (Production, Companion), By Mode Of Delivery (Oral, Parenteral), By End Use, And Segment Forecasts, 2022 - 2030

出版日: | 発行: Grand View Research, Inc. | ページ情報: 英文 200 Pages | 納期: 2~10営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=128.85円
動物用医薬品の市場規模・市場シェア・動向分析 (2022-2030年):製品 (生物製剤・医薬品)・動物タイプ (生産動物・コンパニオンアニマル)・送達区分 (経口・非経口)・エンドユーザー別
出版日: 2022年03月23日
発行: Grand View Research, Inc.
ページ情報: 英文 200 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の動物用医薬品の市場規模は予測期間中7.3%のCAGRで推移し、2030年には546億米ドルの規模に成長すると予測されています。

慢性疾患の有病率の増加や慢性疾患を患う犬に対する高度な治療選択肢に対する需要の高まりにより、コンパニオンアニマルの部門は予測期間中に最大の成長を示すと予想されています。新型コロナウイルス感染症 (COVID-19) による規制緩和から、近い将来、動物用医薬品の製造および採用が増加すると予想されます。

当レポートでは、世界の動物用医薬品の市場を調査し、市場概要、市場成長への各種影響因子の分析、法規制環境、市場規模の推移・予測、製品・送達区分・エンドユーザー・地域/主要国など各種区分別の内訳、競合環境、市場シェア、主要企業のプロファイルなどをまとめています。

目次

第1章 調査手法・調査範囲

第2章 エグゼクティブサマリー

第3章 動物用医薬品市場の可変因子・動向・展望

  • 市場系統の見通し
  • 普及・成長の見通しマッピング
  • 市場力学
  • ポーターの分析
  • PESTEL分析
  • 規制の枠組み
  • COVID-19の影響

第4章 動物用医薬品市場:競合分析

  • 参入事業者の分類
  • 公開企業
  • 非公開企業
  • ベンダー情勢

第5章 動物用医薬品市場:動物タイプ別の推計・動向分析

  • 市場シェア分析
  • ダッシュボード
  • 生産動物
    • 家禽
    • 羊・山羊
  • コンパニオンアニマル
    • その他

第6章 動物用医薬品市場:製品別の推計・動向分析

  • 市場シェア分析
  • ダッシュボード
  • 生物製剤
    • ワクチン
  • その他
  • 医薬品
    • 寄生虫駆除剤
    • 抗感染薬
    • 抗炎症薬
    • 鎮痛薬
    • その他
  • 薬用飼料添加物

第7章 動物用医薬品市場:送達区分別の推計・動向分析

  • 市場シェア分析
  • ダッシュボード
  • 経口
    • 粉末
    • タブレット
  • 非経口
  • 懸濁液
  • 局所剤
  • キャリア

第8章 動物用医薬品市場:エンドユーザー別の推計・動向分析

  • 市場シェア分析
  • ダッシュボード
  • リファレンスラボ
  • 獣医病院・クリニック
  • ポイントオブケア/インハウステスト
  • その他

第9章 動物用医薬品市場:地域・動物タイプ・製品・送達区分・エンドユーザー別の推計・動向分析

  • 地域市場のスナップショット
  • 国別の市場シェア分析
  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東・アフリカ

第10章 企業プロファイル

  • Merck Animal Health
  • Ceva Sante Animale
  • Vetoquinol S.A.
  • Zoetis
  • Boehringer Ingelheim GmbH
  • Elanco
  • Nutreco N.V.
  • Virbac
  • Kindred Biosciences, Inc.
  • Biogenesis Bago
  • Indian Immunologicals Ltd.
  • Neogen Corporation
  • Hester Biosciences
  • Phibro Animal Health
図表

List of Tables

  • TABLE 1 Primary interview details: North America
  • TABLE 2 Primary interview details: Europe
  • TABLE 3 Primary interview details: APAC
  • TABLE 4 Primary interview details: Latin America
  • TABLE 5 Primary interview details: MEA
  • TABLE 6 List of secondary sources
  • TABLE 7 List of Veterinary Medicine By Dosage Form
  • TABLE 8 List of parenteral drugs
  • TABLE 9 Vaccination schedule for dogs: core and non-core vaccines
  • TABLE 10 Vaccination schedule for cats: core and non-core vaccines
  • TABLE 11 North America Veterinary Medicine market estimates and forecasts, by product, 2017 - 2030 (USD million)
  • TABLE 12 North America Veterinary Medicine market estimates and forecasts, by animal types, 2017 - 2030 (USD million)
  • TABLE 13 North America Veterinary Medicine market estimates and forecasts, by mode of delivery, 2017 - 2030 (USD million)
  • TABLE 14 North America Veterinary Medicine market estimates and forecasts, by end use, 2017 - 2030 (USD million)
  • TABLE 15 U.S. Veterinary Medicine market estimates and forecasts, by product, 2017 - 2030 (USD million)
  • TABLE 16 U.S. Veterinary Medicine market estimates and forecasts, by animal types, 2017 - 2030 (USD million)
  • TABLE 17 U.S. Veterinary Medicine market estimates and forecasts, by mode of delivery, 2017 - 2030 (USD million)
  • TABLE 18 U.S. Veterinary Medicine market estimates and forecasts, by end use, 2017 - 2030 (USD million)
  • TABLE 19 Canada Veterinary Medicine market estimates and forecasts, by product, 2017 - 2030 (USD million)
  • TABLE 20 Canada Veterinary Medicine market estimates and forecasts, by animal types, 2017 - 2030 (USD million)
  • TABLE 21 Canada Veterinary Medicine market estimates and forecasts, by mode of delivery, 2017 - 2030 (USD million)
  • TABLE 22 Canada Veterinary Medicine market estimates and forecasts, by end use, 2017 - 2030 (USD million)
  • TABLE 23 Europe Veterinary Medicine market estimates and forecasts, by product, 2017 - 2030 (USD million)
  • TABLE 24 Europe Veterinary Medicine market estimates and forecasts, by animal types, 2017 - 2030 (USD million)
  • TABLE 25 Europe Veterinary Medicine market estimates and forecasts, by mode of delivery, 2017 - 2030 (USD million)
  • TABLE 26 Europe Veterinary Medicine market estimates and forecasts, by end use, 2017 - 2030 (USD million)
  • TABLE 27 U.K. Veterinary Medicine market estimates and forecasts, by product, 2017 - 2030 (USD million)
  • TABLE 28 U.K. Veterinary Medicine market estimates and forecasts, by animal types, 2017 - 2030 (USD million)
  • TABLE 29 U.K. Veterinary Medicine market estimates and forecasts, by mode of delivery, 2017 - 2030 (USD million)
  • TABLE 30 U.K. Veterinary Medicine market estimates and forecasts, by end use, 2017 - 2030 (USD million)
  • TABLE 31 Germany Veterinary Medicine market estimates and forecasts, by product, 2017 - 2030 (USD million)
  • TABLE 32 Germany Veterinary Medicine market estimates and forecasts, by animal types, 2017 - 2030 (USD million)
  • TABLE 33 Germany Veterinary Medicine market estimates and forecasts, by mode of delivery, 2017 - 2030 (USD million)
  • TABLE 34 Germany Veterinary Medicine market estimates and forecasts, by end use, 2017 - 2030 (USD million)
  • TABLE 35 France Veterinary Medicine market estimates and forecasts, by product, 2017 - 2030 (USD million)
  • TABLE 36 France Veterinary Medicine market estimates and forecasts, by animal types, 2017 - 2030 (USD million)
  • TABLE 37 France Veterinary Medicine market estimates and forecasts, by mode of delivery, 2017 - 2030 (USD million)
  • TABLE 38 France Veterinary Medicine market estimates and forecasts, by end use, 2017 - 2030 (USD million)
  • TABLE 39 Italy Veterinary Medicine market estimates and forecasts, by product, 2017 - 2030 (USD million)
  • TABLE 40 Italy Veterinary Medicine market estimates and forecasts, by animal types, 2017 - 2030 (USD million)
  • TABLE 41 Italy Veterinary Medicine market estimates and forecasts, by mode of delivery, 2017 - 2030 (USD million)
  • TABLE 42 Italy Veterinary Medicine market estimates and forecasts, by end use, 2017 - 2030 (USD million)
  • TABLE 43 Spain Veterinary Medicine market estimates and forecasts, by product, 2017 - 2030 (USD million)
  • TABLE 44 Spain Veterinary Medicine market estimates and forecasts, by animal types, 2017 - 2030 (USD million)
  • TABLE 45 Spain Veterinary Medicine market estimates and forecasts, by mode of delivery, 2017 - 2030 (USD million)
  • TABLE 46 Spain Veterinary Medicine market estimates and forecasts, by end use, 2017 - 2030 (USD million)
  • TABLE 47 Asia Pacific Veterinary Medicine market estimates and forecasts, by product, 2017 - 2030 (USD million)
  • TABLE 48 Asia Pacific Veterinary Medicine market estimates and forecasts, by animal types, 2017 - 2030 (USD million)
  • TABLE 49 Asia Pacific Veterinary Medicine market estimates and forecasts, by mode of delivery, 2017 - 2030 (USD million)
  • TABLE 50 Asia Pacific Veterinary Medicine market estimates and forecasts, by end use, 2017 - 2030 (USD million)
  • TABLE 51 Japan Veterinary Medicine market estimates and forecasts, by product, 2017 - 2030 (USD million)
  • TABLE 52 Japan Veterinary Medicine market estimates and forecasts, by animal types, 2017 - 2030 (USD million)
  • TABLE 53 Japan Veterinary Medicine market estimates and forecasts, by mode of delivery, 2017 - 2030 (USD million)
  • TABLE 54 Japan Veterinary Medicine market estimates and forecasts, by end use, 2017 - 2030 (USD million)
  • TABLE 55 China Veterinary Medicine market estimates and forecasts, by product, 2017 - 2030 (USD million)
  • TABLE 56 China Veterinary Medicine market estimates and forecasts, by animal types, 2017 - 2030 (USD million)
  • TABLE 57 China Veterinary Medicine market estimates and forecasts, by mode of delivery, 2017 - 2030 (USD million)
  • TABLE 58 China Veterinary Medicine market estimates and forecasts, by end use, 2017 - 2030 (USD million)
  • TABLE 59 India Veterinary Medicine market estimates and forecasts, by product, 2017 - 2030 (USD million)
  • TABLE 60 India Veterinary Medicine market estimates and forecasts, by animal types, 2017 - 2030 (USD million)
  • TABLE 61 India Veterinary Medicine market estimates and forecasts, by end use, 2017 - 2030 (USD million)
  • TABLE 62 India Veterinary Medicine market estimates and forecasts, by mode of delivery, 2017 - 2030 (USD million)
  • TABLE 63 Latin America Veterinary Medicine market estimates and forecasts, by product, 2017 - 2030 (USD million)
  • TABLE 64 Latin America Veterinary Medicine market estimates and forecasts, by animal types, 2017 - 2030 (USD million)
  • TABLE 65 Latin America Veterinary Medicine market estimates and forecasts, by mode of delivery, 2017 - 2030 (USD million)
  • TABLE 66 Latin America Veterinary Medicine market estimates and forecasts, by end use, 2017 - 2030 (USD million)
  • TABLE 67 Brazil Veterinary Medicine market estimates and forecasts, by product, 2017 - 2030 (USD million)
  • TABLE 68 Brazil Veterinary Medicine market estimates and forecasts, by animal types, 2017 - 2030 (USD million)
  • TABLE 69 Brazil Veterinary Medicine market estimates and forecasts, by mode of delivery, 2017 - 2030 (USD million)
  • TABLE 70 Brazil Veterinary Medicine market estimates and forecasts, by end use, 2017 - 2030 (USD million)
  • TABLE 71 Mexico Veterinary Medicine market estimates and forecasts, by product, 2017 - 2030 (USD million)
  • TABLE 72 Mexico Veterinary Medicine market estimates and forecasts, by animal types, 2017 - 2030 (USD million)
  • TABLE 73 Mexico Veterinary Medicine market estimates and forecasts, by mode of delivery, 2017 - 2030 (USD million)
  • TABLE 74 Mexico Veterinary Medicine market estimates and forecasts, by end use, 2017 - 2030 (USD million)
  • TABLE 75 Argentina Veterinary Medicine market estimates and forecasts, by product, 2017 - 2030 (USD million)
  • TABLE 76 Argentina Veterinary Medicine market estimates and forecasts, by animal types, 2017 - 2030 (USD million)
  • TABLE 77 Argentina Veterinary Medicine market estimates and forecasts, by mode of delivery, 2017 - 2030 (USD million)
  • TABLE 78 Argentina Veterinary Medicine market estimates and forecasts, by end use, 2017 - 2030 (USD million)
  • TABLE 79 MEA Veterinary Medicine market estimates and forecasts, by product, 2017 - 2030 (USD million)
  • TABLE 80 MEA Veterinary Medicine market estimates and forecasts, by animal types, 2017 - 2030 (USD million)
  • TABLE 81 MEA Veterinary Medicine market estimates and forecasts, by mode of delivery, 2017 - 2030 (USD million)
  • TABLE 82 MEA Veterinary Medicine market estimates and forecasts, by end use, 2017 - 2030 (USD million)
  • TABLE 83 South Africa Veterinary Medicine market estimates and forecasts, by product, 2017 - 2030 (USD million)
  • TABLE 84 South Africa Veterinary Medicine market estimates and forecasts, by animal types, 2017 - 2030 (USD million)
  • TABLE 85 South Africa Veterinary Medicine market estimates and forecasts, by mode of delivery, 2017 - 2030 (USD million)
  • TABLE 86 South Africa Veterinary Medicine market estimates and forecasts, by end use, 2017 - 2030 (USD million)
  • TABLE 87 Saudi Arabia Veterinary Medicine market estimates and forecasts, by product, 2017 - 2030 (USD million)
  • TABLE 88 Saudi Arabia Veterinary Medicine market estimates and forecasts, by animal types, 2017 - 2030 (USD million)
  • TABLE 89 Saudi Arabia Veterinary Medicine market estimates and forecasts, by mode of delivery, 2017 - 2030 (USD million)
  • TABLE 90 Saudi Arabia Veterinary Medicine market estimates and forecasts, by end use, 2017 - 2030 (USD million)
  • TABLE 91 Major merger & acquisitions
  • TABLE 92 List of key emerging companies
  • TABLE 93 List of key private companies
  • TABLE 94 List of Distributors

List of Figures

  • Fig. 1 Market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Primary interviews in North America
  • Fig. 6 Primary interviews in Europe
  • Fig. 7 Primary interviews in APAC
  • Fig. 8 Primary interviews in Latin America
  • Fig. 9 Primary interviews in MEA
  • Fig. 10 Market research approaches
  • Fig. 11 Value-chain-based sizing & forecasting
  • Fig. 12 QFD modeling for market share assessment
  • Fig. 13 Market formulation & validation
  • Fig. 14 Commodity flow analysis
  • Fig. 15 Veterinary medicine market revenue, 2017 - 2030 (USD Million)
  • Fig. 16 veterinary medicine market snapshot
  • Fig. 17 Animal health market revenue, 2017 - 2030 (USD Million)
  • Fig. 18 Penetration & growth prospect mapping
  • Fig. 19 Veterinary medicine market dynamics
  • Fig. 20 Veterinary medicine market driver impact
  • Fig. 21 Veterinary medicine market restraint impact
  • Fig. 22 Market participant categorization
  • Fig. 23 Company market position analysis
  • Fig. 24 Market differentiators
  • Fig. 25 Company market share analysis
  • Fig. 26 Veterinary medicine market animal type dashboard
  • Fig. 27 Veterinary medicine market: Animal type movement analysis
  • Fig. 28 Global production animal market, 2017 - 2030 (USD Million)
  • Fig. 29 Poultry diseases prevalence analysis (2019)
  • Fig. 30 Global poultry market, 2017 - 2030 (USD Million)
  • Fig. 31 Global swine market, 2017 - 2030 (USD Million)
  • Fig. 32 Global cattle market, 2017 - 2030 (USD Million)
  • Fig. 33 Global sheep & goats market, 2017 - 2030 (USD Million)
  • Fig. 34 Global fish market, 2017 - 2030 (USD Million)
  • Fig. 35 Global companion animal market, 2017 - 2030 (USD Million)
  • Fig. 36 Dogs diseases prevalence analysis (2019)
  • Fig. 37 Global dogs market, 2017 - 2030 (USD Million)
  • Fig. 38 Cats diseases prevalence analysis (2019)
  • Fig. 39 Global cats market, 2017 - 2030 (USD Million)
  • Fig. 40 Global horses market, 2017 - 2030 (USD Million)
  • Fig. 41 Global others market, 2017 - 2030 (USD Million)
  • Fig. 42 Veterinary medicine Product dashboard
  • Fig. 43 Veterinary medicine market: Product movement analysis
  • Fig. 44 Global biologics market, 2017 - 2030 (USD Million)
  • Fig. 45 Global vaccines market, 2017 - 2030 (USD Million)
  • Fig. 46 Live attenuated vaccines market, 2017 - 2030 (USD Million)
  • Fig. 47 DNA Vaccines market, 2017 - 2030 (USD Million)
  • Fig. 48 Recombinant Vaccines market, 2017 - 2030 (USD Million)
  • Fig. 49 Inactivated Vaccines market, 2017 - 2030 (USD Million)
  • Fig. 50 Other vaccines market, 2017 - 2030 (USD Million)
  • Fig. 51 Global other biologics market, 2017 - 2030 (USD Million)
  • Fig. 52 Global pharmaceuticals market, 2017 - 2030 (USD Million)
  • Fig. 53 Parasiticides market, 2017 - 2030 (USD Million)
  • Fig. 54 Anti-infectives market, 2017 - 2030 (USD Million)
  • Fig. 55 Anti-inflammatory market, 2017 - 2030 (USD Million)
  • Fig. 56 Analgesics market, 2017 - 2030 (USD Million)
  • Fig. 57 Other pharmaceuticals market, 2017 - 2030 (USD Million)
  • Fig. 58 Veterinary medicine Mode of delivery dashboard
  • Fig. 59 Veterinary medicine market: Mode of delivery movement analysis
  • Fig. 60 Global oral market, 2017 - 2030 (USD Million)
  • Fig. 61 Global tablet market, 2017 - 2030 (USD Million)
  • Fig. 62 Global powder market, 2017 - 2030 (USD Million)
  • Fig. 63 Global parenteral market, 2017 - 2030 (USD Million)
  • Fig. 64 Global suspension market, 2017 - 2030 (USD Million)
  • Fig. 65 Global topical market, 2017 - 2030 (USD Million)
  • Fig. 66 Global carrier market, 2017 - 2030 (USD Million)
  • Fig. 67 Veterinary medicine market End Use movement analysis
  • Fig. 68 Veterinary medicine End use dashboard
  • Fig. 69 Reference Laboratories market, 2017 - 2030 (USD Million)
  • Fig. 70 Point-of-care testing/In-house testing market, 2017 - 2030 (USD Million)
  • Fig. 71 Veterinary Hospitals & Clinics market, 2017 - 2030 (USD Million)
  • Fig. 72 Others market, 2017 - 2030 (USD Million)
  • Fig. 73 Veterinary medicine Regional dashboard
  • Fig. 74 Veterinary medicine market Regional movement analysis
  • Fig. 75 North America Veterinary Medicine market estimates and forecasts, 2016 - 2028 (USD million)
  • Fig. 76 U.S. Veterinary Medicine market estimates and forecasts, 2016 - 2028 (USD million)
  • Fig. 77 Canada Veterinary Medicine market estimates and forecasts, 2016 - 2028 (USD million)
  • Fig. 78 Europe Veterinary Medicine market estimates and forecasts, 2016 - 2028 (USD million)
  • Fig. 79 U.K. Veterinary Medicine market estimates and forecasts, 2016 - 2028 (USD million)
  • Fig. 80 Germany Veterinary Medicine market estimates and forecasts, 2016 - 2028 (USD million)
  • Fig. 81 France Veterinary Medicine market estimates and forecasts, 2016 - 2028 (USD million)
  • Fig. 82 Italy Veterinary Medicine market estimates and forecasts, 2016 - 2028 (USD million)
  • Fig. 83 Spain Veterinary Medicine market estimates and forecasts, 2016 - 2028 (USD million)
  • Fig. 84 Russia Veterinary Medicine market estimates and forecasts, 2016 - 2028 (USD million)
  • Fig. 85 Asia Pacific Veterinary Medicine market estimates and forecasts, 2016 - 2028 (USD million)
  • Fig. 86 Japan Veterinary Medicine market estimates and forecasts, 2016 - 2028 (USD million)
  • Fig. 87 China Veterinary Medicine market estimates and forecasts, 2016 - 2028 (USD million)
  • Fig. 88 India Veterinary Medicine market estimates and forecasts, 2016 - 2028 (USD million)
  • Fig. 89 Latin America Veterinary Medicine market estimates and forecasts, 2016 - 2028 (USD million)
  • Fig. 90 Brazil Veterinary Medicine market estimates and forecasts, 2016 - 2028 (USD million)
  • Fig. 91 Mexico Veterinary Medicine market estimates and forecasts, 2016 - 2028 (USD million)
  • Fig. 92 Argentina Veterinary Medicine market estimates and forecasts, 2016 - 2028 (USD million)
  • Fig. 93 Middle East & Africa Veterinary Medicine market estimates and forecasts, 2016 - 2028 (USD million)
  • Fig. 94 South Africa Veterinary Medicine market estimates and forecasts, 2016 - 2028 (USD million)
  • Fig. 95 Saudi Arabia Veterinary Medicine market estimates and forecasts, 2016 - 2028 (USD million)
目次
Product Code: GVR-3-68038-885-5

Veterinary Medicine Market Growth & Trends

The global veterinary medicine market size is expected to reach USD 54.6 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to register a CAGR of 7.3% over the forecast period. The companion animal segment is anticipated to demonstrate the fastest growth during the forecast period owing to the increasing prevalence of chronic diseases and rising demand for advanced treatment alternatives for canines suffering from chronic diseases. The COVID-19 pandemic resulted in regulatory changes, which are anticipated to iron out the disruptions, thereby increasing manufacturing and adoption of vet medicines in near future.

The federal government has taken various relief measures, which include new tax provisions, small business loans, and unemployment insurance to respond to the pandemic and support the veterinarians. AVMA has also taken supportive measures to support small veterinary businesses or practices. In August 2020, the USFDA stated that 6 out of 32 animal drug companies could soon face shortages who source their API from China. Due to labor shortage, there is also reduced capacity to work on animal health activities, such as vaccination, good biosecurity, and prophylactic treatment. The manufacturing units are taking preventive measures for the uninterrupted production of veterinary drugs.

The growing consumption of meat is fueling the demand for mandatory vaccination for animals, which results in market growth. According to The World Counts, meat consumption is estimated to range between 460-570 million tons by 2050. Such factors are expected to drive the demand for medicinal feed additives & antibiotics to boost livestock production and thereby fueling the market growth. An increase in the consumption of animal-based products, recent developments in feed production, implementation of innovative animal husbandry practices to advance meat quality, and standardization of meat products due to disease outbreaks have also boosted the demand for animal feeds, thereby creating growth opportunities for the companies operating in this space.

The new regulations on veterinary medicines and medicated feed enforced from January 2022 within the European Union are expected to support European Union action to fight against antimicrobial resistance. These types of supportive initiatives undertaken by regulatory bodies to keep antimicrobials (comprising antibiotics) effective based on a 'One health' approach are expected to maintain animal and public health. Moreover, it also improves the access to high-quality & safe-to-use medicines for livestock farmers, veterinarians, and pet owners. The market leaders are involved in strategic collaborations, acquisitions, investments in new product segments, mergers, and new product launches to sustain the competition.

For instance, in July 2021, Nutreco acquired Bigsal Nutricao Animal from H.I.G. Capital in Brazil. This strengthened the company's position in the animal nutrition space, of the Brazilian market. In February 2021, Virbac opened the R&D facility dedicated to warm water aquaculture in Vietnam. The new facility would enable the development of vaccines, probiotics, and other products for aquatics. Initiatives like these are anticipated to propel market growth in the coming years. In October 2021, Boehringer Ingelheim invested an additional USD 112.68 million in its veterinary public health capacity in Lyon-Jonage, France. This new capacity will be one of the largest biotechnology manufacturing sites for veterinary vaccines in Europe. Leading players have maintained their market position in terms of product penetration, regional presence, revenue, as well as strategic initiatives.

Veterinary Medicine Market Report Highlights

The production animal segment is projected to register a significant CAGR over the forecast period. Increasing focus on food safety and sustainability by government healthcare organizations globally is contributing to the segment growth

The biologics segment, which includes vaccines, is expected to exhibit the fastest CAGR over the forecast period owing to the increasing awareness regarding the importance of vaccination in animals

The oral mode of administration is expected to grow at the fastest growth rate from 2022 to 2030 owing to the increasing incidence of chronic conditions in pets

The reference laboratories segment is anticipated to witness lucrative growth in the coming years due to the high demand as laboratories enable testing of various infections, toxic agents, and different ailments in specimens obtained from pets

North America held the second-largest revenue share in 2021, due to the high prevalence of zoonotic diseases in this region. Moreover, reimbursement programs across the U.S. make this continent a major contributor to the market

Asia Pacific is anticipated to witness the fastest CAGR from 2022 to 2030 owing to the rising adoption of pet animals, growing concerns regarding animal health, and the high prevalence of diseases in animals

Table Of Contents

Chapter 1 Research Methodology & Scope

  • 1.1 Market Segmentation & Scope
    • 1.1.1 Estimates And Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database:
    • 1.3.2 Gvr's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research:
    • 1.3.5 Details Of Primary Research
    • 1.3.6 Data For Primary Interviews In North America
    • 1.3.7 Data For Primary Interviews In Europe
    • 1.3.8 Data For Primary Interviews In Asia Pacific
    • 1.3.9 Data For Primary Interviews In Latin America
    • 1.3.10 Data For Primary Interviews In MeA
  • 1.4 Information or Data Analysis
    • 1.4.1 Data Analysis ModelS
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis (Model 1)
      • 1.6.1.1 Approach 1: Commodity Flow Approach
  • 1.7 List of Secondary Sources
  • 1.8 List of Primary Sources
  • 1.9 Report Objectives

Chapter 2 Executive Summary

  • 2.1 Market Outlook
    • 2.1.1 Veterinary Medicine Market Outlook, 2017-2030 (USD Million)
  • 2.2 Segment Outlook
  • 2.3 Competitive Outlook
  • 2.4 Veterinary Medicine Market Summary, 2021

Chapter 3 Veterinary Medicine Market Variables, Trends & Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent Market Analysis
      • 3.1.1.1 Animal health Market Outlook, 2017 - 2030 (USD Million)
  • 3.2 Penetration & Growth Prospect Mapping
  • 3.3 Veterinary Medicine Market Dynamics
    • 3.3.1 Market Driver Analysis
      • 3.3.1.1 Rise in livestock population and increasing pet ownership rates
      • 3.3.1.2 Increase in number of Zoonotic & Chronic diseases
      • 3.3.1.3 Rising R&D and procedural advancements
      • 3.3.1.4 Increasing consumption of meats and mandatory vaccination
    • 3.3.2 Market Restraint Analysis
      • 3.3.2.1 Government intervention
      • 3.3.2.2 Increasing influx of counterfeit drugs
      • 3.3.2.3 Short product exclusivity period
  • 3.4 Veterinary Medicine Market Analysis Tools: Porters
    • 3.4.1 Supplier Power:
    • 3.4.2 Buyer Power:
    • 3.4.3 Threat Of Substitutes:
    • 3.4.4 Threat Of New Entrants:
    • 3.4.5 Competitive Rivalary
  • 3.5 PESTEL Analysis
    • 3.5.1 Political & Legal Landscape
    • 3.5.2 Economic & Social Landscape
    • 3.5.3 Technology Landscape
    • 3.5.4 Social Landscape
  • 3.6 Regulatory Framework
  • 3.7 Covid-19 Impact
    • 3.6.1 Disease Prevalence Analysis
    • 3.6.2 Current & Future Impact Analysis
    • 3.6.3 Impact on market players

Chapter 4 Veterinary Medicine Market: Competitive Analysis

  • 4.1 Market Participation Categorization
  • 4.2 Public Companies
    • 4.2.1 Company Market Position Analysis
    • 4.2.2 Competitive Dashboard Analysis
    • 4.2.3 Major Deals & Acquisitions
    • 4.2.4 Estimated Company Market Share Analysis, 2021
  • 4.3 Private Companies
    • 4.3.1 List Of Private Companies
  • 4.4 Vendor Landscape
    • 4.4.1 List Of Distributors

Chapter 5 Veterinary Medicine Market: Animal Type Estimates & Trend Analysis

  • 5.1 Animal type Market Share Analysis, 2021 & 2030
  • 5.2 Animal type Dashboard
  • 5.3 Production Animal
    • 5.3.1 PRODUCTION ANIMAL MARKET ESTIMATES AND FORECASTS, 2017 - 2030 (USD MILLION)
    • 5.3.2 Poultry
      • 5.3.2.1 Poultry diseases prevalence analysis (2019)
      • 5.3.2.2 Poultry market estimates and forecasts, 2017 - 2030 (USD Million)
    • 5.3.3 Swine
      • 5.3.3.1 Swine market estimates and forecasts, 2017 - 2030 (USD Million)
    • 5.3.4 Cattle
      • 5.3.4.1 Cattle market estimates and forecasts, 2017 - 2030 (USD Million)
    • 5.3.5 Sheep & Goats
      • 5.3.5.1 Sheep & goats market estimates and forecasts, 2017 - 2030 (USD Million)
    • 5.3.6 FISH
      • 5.3.6.1 Fish market estimates and forecasts, 2017 - 2030 (USD Million)
  • 5.4 Companion Animal
    • 5.4.1 Companion Animal Market Estimates And Forecasts, 2017 - 2030 (USD Million)
    • 5.4.2 Dogs
      • 5.4.2.1 Dogs diseases prevalence analysis (2019)
      • 5.4.2.2 Dogs core vaccination protocol:
      • 5.4.2.3 Dogs non-core optional vaccination protocol
      • 5.4.2.4 Vaccination Schedule for Dogs: Core and Non-core Vaccines
      • 5.4.2.5 Dogs market estimates and forecasts, 2017 - 2030 (USD Million)
    • 5.4.3 Cats
      • 5.4.3.1 Cats diseases prevalence analysis (2019)
      • 5.4.3.2 Cats core vaccination protocol:
      • 5.4.3.3 Cats non-core optional vaccination protocol
      • 5.4.3.4 Vaccination Schedule for Cats: Core and Non-core Vaccines
      • 5.4.3.5 Cats market estimates and forecasts, 2017 - 2030 (USD Million)
    • 5.4.4 Horses
      • 5.4.4.1 Horses market estimates and forecasts, 2017 - 2030 (USD Million)
    • 5.4.5 Others
      • 5.4.5.1 Others market estimates and forecasts, 2017 - 2030 (USD Million)

Chapter 6 Veterinary Medicine Market: Product Estimates & Trend Analysis

  • 6.1 Product Market Share Analysis, 2021 & 2030
  • 6.2 Product Dashboard
  • 6.3 Biologics
    • 6.3.1 Biologics Market Estimates And Forecasts, 2017 - 2030 (USD Million)
    • 6.3.2 Vaccines
      • 6.3.2.1 Vaccines market estimates and forecasts, 2017 - 2030 (USD Million)
      • 6.3.2.2 Live attenuated vaccines
      • 6.3.2.3 Live attenuated vaccines market estimates and forecasts, 2017 - 2030 (USD Million)
      • 6.3.2.4 DNA vaccines
      • 6.3.2.5 DNA vaccines market estimates and forecasts, 2017 - 2030 (USD Million)
      • 6.3.2.6 Recombinant vaccines
      • 6.3.2.7 Recombinant vaccines market estimates and forecasts, 2017 - 2030 (USD Million)
      • 6.3.2.8 Inactivated vaccines
      • 6.3.2.9 Inactivated vaccines market estimates and forecasts, 2017 - 2030 (USD Million)
      • 6.3.2.10 Others
      • 6.3.2.11 Others market estimates and forecasts, 2017 - 2030 (USD Million)
  • 6.4 Others
    • 6.4.1 Others Market Estimates And Forecasts, 2017 - 2030 (USD Million)
  • 6.5 Pharmaceuticals
    • 6.5.1 Pharmaceuticals Market Estimates And Forecasts, 2017 - 2030 (USD Million)
    • 6.5.2 Parasiticides
      • 6.5.2.1 Parasiticides market estimates and forecasts, 2017 - 2030 (USD Million)
    • 6.5.3 Anti-Infectives
      • 6.5.3.1 Anti-infectives market estimates and forecasts, 2017 - 2030 (USD Million)
    • 6.5.4 Anti-Inflammatory
      • 6.5.4.1 Anti-inflammatory market estimates and forecasts, 2017 - 2030 (USD Million)
    • 6.5.5 Analgesics
      • 6.5.5.1 Analgesics market estimates and forecasts, 2017 - 2030 (USD Million)
    • 6.5.6 Others
      • 6.5.6.1 Others market estimates and forecasts, 2017 - 2030 (USD Million)
  • 6.6 Medicinal feed additives
    • 6.6.1 Medicinal Feed Additives Market Estimates And Forecasts, 2017 - 2030 (USD Million)

Chapter 7 Veterinary Medicine Market: Mode of Delivery Estimates & Trend Analysis

  • 7.1 Mode of delivery Market Share Analysis, 2021 & 2030
  • 7.2 Mode of delivery dashboard
  • 7.3 Oral
    • 7.3.1 Oral Market Estimates And ForecastS, 2017 - 2030 (USD Million)
    • 7.3.2 Powder
      • 7.3.2.1 Powder market estimates and forecasts, 2017 - 2030 (USD Million)
    • 7.3.3 Tablets
      • 7.3.3.1 Tablets market estimates and forecasts, 2017 - 2030 (USD Million)
  • 7.4 Parenteral
    • 7.4.1 Parenteral Market Estimates And Forecasts, 2017 - 2030 (USD Million)
  • 7.5. Suspension
    • 7.5.1 Suspension Market Estimates And Forecasts, 2017 - 2030 (USD Million)
  • 7.6 Topical
    • 7.6.1 Topical Market Estimates And Forecasts, 2017 - 2030 (USD Million)
  • 7.7 Carrier
    • 7.7.1 Carrier market estimates and forecasts, 2017 - 2030 (USD Million)

Chapter 8 Veterinary Medicine Market: End-use Estimates & Trend Analysis

  • 8.1 End-Use Market Share Analysis, 2021 & 2030
  • 8.2 End-Use Dashboard
  • 8.3 Reference Laboratories
    • 8.3.1 Reference Laboratories Market Estimates And Forecasts, 2017 - 2030 (USD Million)
  • 8.4 Veterinary Hospitals And Clinics
    • 8.4.1 Veterinary Hospitals And Clinics Market Estimates And Forecasts, 2017 - 2030 (USD Million)
  • 8.5 Point-Of-Care/In-House Testing
    • 8.5.1 Point-Of-Care/In-House Testing Market Estimates And Forecasts, 2017 - 2030 (USD Million)
  • 8.6 Others
    • 8.6.1 Others Market Estimates And Forecasts, 2017 - 2030 (USD Million)

Chapter 9 Veterinary Medicine Market: Regional Estimates & Trend Analysis, By, Animal Type, Product, Mode Of Delivery And End-Use

  • 9.1 Regional Market Snapshot
  • 9.2 Market Share Analysis by Country, 2021
    • 9.2.1 North America
    • 9.2.2 Europe
    • 9.2.3 Asia Pacific
    • 9.2.4 Latin America
    • 9.2.5 Mea
  • 9.3 North America
    • 9.3.1 North America Veterinary Medicine Market Estimates And Forecasts, 2017 - 2030 (USD Million)
    • 9.3.2 U.S.
      • 9.3.2.1 U.S. Veterinary Medicine Market Estimates And Forecasts, 2017 - 2030(USD Million)
    • 9.3.3 Canada
      • 9.3.3.1 Canada Veterinary Medicine Market Estimates And Forecasts, 2017 - 2030(USD Million)
  • 9.4 Europe
    • 9.4.1 Europe Veterinary Medicine Market Estimates And Forecasts, 2017 - 2030 (USD Million)
    • 9.4.2 U.K.
      • 9.4.2.1 U.K. Veterinary Medicine Market Estimates And Forecasts, 2017 - 2030(USD Million)
    • 9.4.3 Germany
      • 9.4.3.1 Germany Veterinary Medicine Market Estimates And Forecasts, 2017 - 2030 (USD Million)
    • 9.4.4 France
      • 9.4.4.1 France Veterinary Medicine Market Estimates And Forecasts, 2017 - 2030 (USD Million)
    • 9.4.5 Italy
      • 9.4.5.1 Italy Veterinary Medicine Market Estimates And Forecasts, 2017 - 2030 (USD Million)
    • 9.4.6 Spain
      • 9.4.6.1 Spain Veterinary Medicine Market Estimates And Forecasts, 2017 - 2030 (USD Million)
    • 9.4.7 Russia
      • 9.4.7.1 Russia Veterinary Medicine Market Estimates And Forecasts, 2017 - 2030 (USD Million)
  • 9.5 Asia Pacific
    • 9.5.1 Asia Pacific Veterinary Medicine Market Estimates And Forecasts, 2017 - 2030 (USD Million)
    • 9.5.2 Japan
      • 9.5.2.1 Japan Veterinary Medicine Market Estimates And Forecasts, 2017 - 2030 (USD Million)
    • 9.5.3 China
      • 9.5.3.1 China Veterinary Medicine Market Estimates And Forecasts, 2017 - 2030 (USD Million)
    • 9.5.4 India
      • 9.5.4.1 India Veterinary Medicine Market Estimates And Forecasts, 2017 - 2030 (USD Million)
  • 9.6 Latin America
    • 9.6.1 Latin America Veterinary Medicine Market Estimates And Forecasts, 2017 - 2030 (USD Million)
    • 9.6.2 Mexico
      • 9.6.2.1 Mexico Veterinary Medicine Market Estimates And Forecasts, 2017 - 2030 (USD Million)
    • 9.6.3 Brazil
      • 9.6.3.1 Brazil veterinary medicine market estimates and forecasts, 2017 - 2030 (USD Million)
    • 9.6.4 Argentina
      • 9.6.4.1 Argentina Veterinary Medicine Market Estimates And Forecasts, 2017 - 2030 (USD Million)
  • 9.7 MEA
    • 9.7.1 MEA Veterinary Medicine Market Estimates And Forecasts, 2017 - 2030 (USD Million)
    • 9.7.2 South Africa
      • 9.7.2.1 South Africa Veterinary Medicine Market Estimates And Forecasts, 2017 - 2030 (USD Million)
    • 9.7.3 Saudi Arabia
      • 9.7.3.1 Saudi Arabia Veterinary Medicine Market Estimates And Forecasts, 2017 - 2030 (USD Million)

Chapter 10 Company Profiles

  • 10.1 Merck Animal Health
    • 10.1.1 Company Overview
    • 10.1.2 Financial Performance
    • 10.1.3 R&D Expenditure
    • 10.1.4 Product Benchmarking
    • 10.1.5 Strategic Initiatives
  • 10.2 Ceva Sante Animale
    • 10.2.1 Company Overview
    • 10.2.2 Financial Performance
    • 10.2.3 Product Benchmarking
    • 10.2.4 Strategic Initiatives
  • 10.3 Vetoquinol S.A.
    • 10.3.1 Company Overview
    • 10.3.2 Financial Performance
    • 10.3.3 Product Benchmarking (Top Products As Per Estimated Revenue (2021)
    • 10.3.4 Strategic Initiatives
  • 10.4 Zoetis
    • 10.4.1 Company Overview
    • 10.4.2 Financial Performance
    • 10.4.3 Product BenchmarkiNG (Top Products As Per Estimated Revenue (2021)
    • 10.4.4 Strategic Initiatives
  • 10.5 Boehringer Ingelheim GmbH
    • 10.5.1 Company Overview
    • 10.5.2 Financial Performance
    • 10.5.3 Product Benchmarking (Top Products As Per Estimated Revenue (2021)
    • 10.5.4 Strategic Initiatives
  • 10.6 Elanco
    • 10.6.1 Company Overview
    • 10.6.2 Financial Performance
    • 10.6.3 Product Benchmarking (Top Ten Products As Per Estimated Revenue (2021)
    • 10.6.4 Strategic Initiatives
  • 10.7 Nutreco N.V.
    • 10.7.1 Company Overview
    • 10.7.2 Product Benchmarking
    • 10.7.3 Strategic Initiatives
  • 10.8 Virbac
    • 10.8.1 Company Overview
    • 10.8.2 Financial Performance
    • 10.8.3 Product Benchmarking (Top Products As Per Estimated Revenue (2021)
    • 10.8.4 Strategic Initiatives
  • 10.9 Kindred Biosciences, Inc.
    • 10.9.1 Company Overview
    • 10.9.2 Financial Performance
    • 10.9.3 R&D Expenditure
    • 10.9.4 Product Benchmarking
    • 10.9.5 Strategic Initiatives
  • 10.10 Biogenesis Bago
    • 10.10.1 Company Overview
    • 10.10.2 Financial Performance
    • 10.10.3 Product Benchmarking
  • 10.11 Indian Immunologicals Ltd.
    • 10.11.1 Company Overview
    • 10.11.2 Financial Performance
    • 10.11.3 Product Benchmarking
    • 10.11.4 Strategic Initiatives
  • 10.12 Neogen Corporation
    • 10.12.1 Company Overview
    • 10.12.2 Financial Performance
    • 10.12.3 Product Benchmarking
    • 10.12.4 Strategic Initiatives
  • 10.13 Hester Biosciences
    • 10.13.1 Company Overview
    • 10.13.2 Financial Performance
    • 10.13.3 R&D Expenditure
    • 10.13.4 PRODUCT BENCHMARKING
  • 10.14 Phibro Animal Health
    • 10.14.1 Company Overview
    • 10.14.2 Financial Performance
    • 10.14.3 R&D Expenditure
    • 10.14.4 Product Benchmarking (Top Products As Per Estimated Revenue (2021)
    • 10.14.5 Strategic Initiatives